Multi-Million-Dollar Manufacturing Investment from Moderna Inc.
Our govt is committed to making Ontario self-reliant. A Multi-million manufacturing investment from Moderna Inc. supported by $4 million through the Ontario Together Fund will ensure Ontarians receive faster and more reliable access to services they deserve.
Moderna is partnering with Novocol Pharma to add new manufacturing capabilities in their Cambridge facility that will complete the final steps of preparing and packaging respiratory mRNA vaccines for distribution in Ontario and throughout Canada. The partnership will create highly skilled jobs for workers in Cambridge and the surrounding region and help the province become more self-sufficient and reliable in case of future health emergencies.
Ontario continues to attract investments and jobs from companies around the world. Over the past two and half years, life sciences companies and global biomanufacturers have invested over $3 billion in investments in Ontario.
- Ontario’s life sciences sector is comprised of a collaborative ecosystem of partners, including hospitals, research centers, universities, technology incubators, start-ups, scientists, and domestic and multinational companies.
- To enhance Ontario’s domestic supply chain capacity, Ontario invested $100 million in the Ontario Together Fund to support manufacturers and innovators like Moderna. In addition to Moderna, the program has announced support for 62 companies and 11 organizations to date.
- To support the next phase of Taking Life Sciences to the Next Level, Ontario’s life sciences strategy, the province has established a Life Sciences Council. This new council will explore ways to support the creation of good-paying jobs, accelerate commercialization and encourage the adoption of Ontario-made innovations to improve health care and grow the economy.
- The health and life sciences sectors employ more than 70,000 people in Ontario. Every year, more than 65,000 STEM students graduate from post-secondary programs across the province, producing one of the most highly skilled life sciences workforces in the world.
- In 2018, Ontario’s life sciences sector generated more than $58.7 billion in revenue. Annually, the life sciences sector exported $11 billion in goods, representing 62 percent of total Canadian life sciences exports.